NRAC
Nutritionally-regulated adipose and cardiac enriched protein homolog
Also known as: C14orf180, C14orf77, NRAC_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N912
- Gene
- NRAC
- Ensembl
- ENSG00000184601
- Chromosome
- 14
- Canonical length
- 160 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
160 residues, UniProt reviewed canonical sequence.
>Q8N912|NRAC
1 MRTAAGAVSP DSRPETRRQT RKNEEAAWGP RVCRAEREDN RKCPPSILKR SRPEHHRPEA
61 KPQRTSRRVW FREPPAVTVH YIADKNATAT VRVPGRPRPH GGSLLLQLCV CVLLVLALGL
121 YCGRAKPVAT ALEDLRARLL GLVLHLRHVA LTCWRGLLRLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NRAC can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.66
- Highest tissue expression
- 103 nTPM
Expression across tissuesHPA
Tissue
- heart muscle: 103 nTPM
- choroid plexus: 41 nTPM
- adipose tissue: 39 nTPM
- breast: 27 nTPM
- blood vessel: 17 nTPM
- skeletal muscle: 5.4 nTPM
Single-cell type
- choroid plexus epithelial cells: 43 nCPM
- ependymal cells: 12 nCPM
- cardiomyocytes: 8.2 nCPM
- adipocytes: 2.9 nCPM
- gastric chief cells: 2.2 nCPM
- epididymal efferent duct ciliated cells: 1.3 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- choroid plexus: 29 nTPM
- hippocampal formation: 3.4 nTPM
- midbrain: 2.2 nTPM
- medulla oblongata: 1.8 nTPM
- thalamus: 1.5 nTPM
- pons: 1.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.55
- gnomAD pLI
- 0
- DepMap mean gene effect
- 0
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Protein of unknown function DUF4658
- Domain of unknown function (DUF4658)
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NRAC as an antibody target. Whether an autoantibody or antibody against NRAC could matter depends on whether native NRAC is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NRAC is annotated at the cell surface, where native NRAC is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label NRAC as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...